Hormone Receptor Expression and QT interval at Baseline Correlate with Trastuzumab Associated Cardiotoxicity in HER2- Positive
Breast Cancer Patients: A Prospective Study
Dana Abo Samra, Ibrahem Hanafi, Dani Abo Samra, Ahmad Naeem, Assef Dayyoub
Springer Nature ·
2025-09-19
· DOI 10.1007/s12012-025-10059-7
The publisher did not provide an abstract — full text is available via the link below.
Dana Abo Samra, Ibrahem Hanafi, Dani Abo Samra, Ahmad Naeem, Assef Dayyoub. Hormone Receptor Expression and QT interval at Baseline Correlate with Trastuzumab Associated Cardiotoxicity in HER2- Positive
Breast Cancer Patients: A Prospective Study. // Cardiovascular Toxicology. – 2025. – DOI: 10.1007/s12012-025-10059-7. – URL: https://doi.org/10.1007/s12012-025-10059-7
Dana Abo Samra, Ibrahem Hanafi, Dani Abo Samra, Ahmad Naeem, & Assef Dayyoub (2025). Hormone Receptor Expression and QT interval at Baseline Correlate with Trastuzumab Associated Cardiotoxicity in HER2- Positive
Breast Cancer Patients: A Prospective Study. Cardiovascular Toxicology. https://doi.org/10.1007/s12012-025-10059-7
Dana Abo Samra, et al. “Hormone Receptor Expression and QT interval at Baseline Correlate with Trastuzumab Associated Cardiotoxicity in HER2- Positive
Breast Cancer Patients: A Prospective Study.” Cardiovascular Toxicology, 2025. doi:10.1007/s12012-025-10059-7.
@article{Samra2025,
title = {Hormone Receptor Expression and QT interval at Baseline Correlate with Trastuzumab Associated Cardiotoxicity in HER2- Positive
Breast Cancer Patients: A Prospective Study},
author = {Samra, Dana Abo and Hanafi, Ibrahem and Samra, Dani Abo and Naeem, Ahmad and Dayyoub, Assef},
journal = {Cardiovascular Toxicology},
year = {2025},
doi = {10.1007/s12012-025-10059-7},
url = {https://doi.org/10.1007/s12012-025-10059-7}
}